Below are the most recent publications written about "Vaccination" by people in Profiles.
-
Anzalone AJ, Sun J, Vinson AJ, Beasley WH, Hillegass WB, Murray K, Hendricks BM, Haendel M, Geary CR, Bailey KL, Hanson CK, Miele L, Horswell R, McMurry JA, Porterfield JZ, Vest MT, Bunnell HT, Harper JR, Price BS, Santangelo SL, Rosen CJ, McClay JC, Hodder SL. Community risks for SARS-CoV-2 infection among fully vaccinated US adults by rurality: A retrospective cohort study from the National COVID Cohort Collaborative. PLoS One. 2023; 18(1):e0279968.
-
Liau LM, Ashkan K, Brem S, Campian JL, Trusheim JE, Iwamoto FM, Tran DD, Ansstas G, Cobbs CS, Heth JA, Salacz ME, D'Andre S, Aiken RD, Moshel YA, Nam JY, Pillainayagam CP, Wagner SA, Walter KA, Chaudhary R, Goldlust SA, Lee IY, Bota DA, Elinzano H, Grewal J, Lillehei K, Mikkelsen T, Walbert T, Abram S, Brenner AJ, Ewend MG, Khagi S, Lovick DS, Portnow J, Kim L, Loudon WG, Martinez NL, Thompson RC, Avigan DE, Fink KL, Geoffroy FJ, Giglio P, Gligich O, Krex D, Lindhorst SM, Lutzky J, Meisel HJ, Nadji-Ohl M, Sanchin L, Sloan A, Taylor LP, Wu JK, Dunbar EM, Etame AB, Kesari S, Mathieu D, Piccioni DE, Baskin DS, Lacroix M, May SA, New PZ, Pluard TJ, Toms SA, Tse V, Peak S, Villano JL, Battiste JD, Mulholland PJ, Pearlman ML, Petrecca K, Schulder M, Prins RM, Boynton AL, Bosch ML. Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial. JAMA Oncol. 2023 Jan 01; 9(1):112-121.
-
Klusaritz H, Paterson E, Summers C, Al-Ramahi N, Naseer N, Jeudin H, Sydnor Y, Enoch M, Dollard N, Young KD, Khan N, Henne J, Doubeni A, Kasbekar N, Gitelman Y, Brennan PJ, Bream K, Cannuscio CC, Wender RC, Feuerstein-Simon R. Community-Based COVID-19 Vaccine Clinics in Medically Underserved Neighborhoods to Improve Access and Equity, Philadelphia, 2021-2022. Am J Public Health. 2022 12; 112(12):1721-1725.
-
Drees M, Weber DJ. Prevention and Control of Nosocomial Varicella During the United States Varicella Vaccination Program Era. J Infect Dis. 2022 10 21; 226(Suppl 4):S456-S462.
-
Saffarian Z, Samii R, Hadizadeh A, Ghanadan A, Vahidnezhad H. Purpuric dermatosis and lymphocytic vasculopathy following SARS-CoV-2 vaccination: Report of two patients. Dermatol Ther. 2022 11; 35(11):e15898.
-
Kelly BJ, Leader AE, Henrikson NB. Editorial: Promising strategies for vaccine messages: The message and the source. Front Public Health. 2022; 10:971283.
-
Olson SM, Newhams MM, Halasa NB, Feldstein LR, Novak T, Weiss SL, Coates BM, Schuster JE, Schwarz AJ, Maddux AB, Hall MW, Nofziger RA, Flori HR, Gertz SJ, Kong M, Sanders RC, Irby K, Hume JR, Cullimore ML, Shein SL, Thomas NJ, Stewart LS, Barnes JR, Patel MM, Randolph AG. Vaccine Effectiveness Against Life-Threatening Influenza Illness in US Children. Clin Infect Dis. 2022 08 25; 75(2):230-238.
-
Gogoi RP, Wallbillich JJ, Winer I, Morris R, Ritchie C, Larson S, Walker J, Bickmore T, Spencer E, Jang H, Kim S, Phalore J, Bui TC. Computer-Animated Relational Agents in Human Papillomavirus Vaccination Education. Obstet Gynecol. 2022 May 01; 139(5):913-915.
-
Shang J, Harrison JM, Chastain AM, Stone PW, Perera UGE, Madigan EA, Pogorzelska-Maziarz M, Dick AW. Influenza vaccination of home health care staff and the impact on patient hospitalizations. Am J Infect Control. 2022 04; 50(4):369-374.
-
Nachtigall I, Bonsignore M, Hohenstein S, Bollmann A, G?nther R, Kodde C, Englisch M, Ahmad-Nejad P, Schr?der A, Glenz C, Kuhlen R, Th?rmann P, Meier-Hellmann A. Effect of gender, age and vaccine on reactogenicity and incapacity to work after COVID-19 vaccination: a survey among health care workers. BMC Infect Dis. 2022 Mar 26; 22(1):291.